Evidence map›Paper›PMID 31659811›Full record

ReviewXenotransplantation2019

Decellularization methods for developing porcine corneal xenografts and future perspectives.

Abdulkadir Isidan, Shaohui Liu, Ping Li, Matthew Lashmet, Lester J Smith, Hidetaka Hara, David K C Cooper, Burcin Ekser

Abstract readReview
In one paragraph

Review in Xenotransplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Transforming meat waste into sustainable corneal keratoplasty models.Frontiers in bioengineering and biotechnology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Pig Models in Retinal Research and Retinal Disease.Cold Spring Harbor perspectives in medicine · 2024
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdulkadir IsidanTransplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0001-6655-1268
Shaohui LiuDepartment of Ophthalmology, Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-9691-9630
Ping LiTransplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0003-1055-9505
Matthew LashmetTransplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-3315-7018
Lester J SmithRadiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0003-4950-7569
Hidetaka HaraXenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-4179-7365
David K C CooperXenotransplantation Program, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-8899-9431
Burcin EkserTransplant Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0003-0741-8007

Funding

Prolonging life-supported pig kidney and heart graft survival in baboons by suppressing inflammationU19AI090959 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COOPER, DAVID KC · 2010 to 2024
$26.3M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Regenova Bio 3D PrinterS10OD023595 · OD · INDIANA UNIVERSITY INDIANAPOLIS · PI SMITH, LESTER J. · 2017 to 2017
$450k
Indiana Clinical and Translational Sciences InstituteIndiana University HealthNCATS NIH HHS UL1 TR001108NIAID NIH HHS U19 AI090959NIH HHS AI090959NIH HHS S10 OD023595NIH HHS S10OD023595NIH HHS UL1TR001108United Therapeutics Corporation
6 · The paper itself

Abstract

Corneal transplantation is the only option to cure corneal opacities. However, there is an imbalance between supply and demand of corneal tissues in the world. To solve the problem of corneal shortage, corneal xenotransplantation studies have been implemented in the past years using porcine corneas. The corneal xenografts could come from (a) wild-type pigs, (b) genetically engineered pigs, (c) decellularized porcine corneas, and (d) decellularized porcine corneas that are recellularized with human corneal cells, eventually with patients' own cells, as in all type of xenografts. All approaches except, the former would reduce or mitigate recipient immune responses. Although several techniques in decellularization have been reported, there is still no standardized protocol for the complete decellularization of corneal tissue. Herein, we reviewed different decellularization methods for porcine corneas based on the mechanism of action, decellularization efficacy, biocompatibility, and the undesirable effects on corneal ultrastructure. We compared 9 decellularization methods including: (a) sodium dodecyl sulfate, (b) triton x-100, (c) hypertonic saline, (d) human serum with electrophoresis, (e) high hydrostatic pressure, (f) freeze-thaw, (h) nitrogen gas, (h) phospholipase A

Indexed as

Corneal TransplantationTransplantation, HeterologousAnimalsCorneaExtracellular MatrixHeterograftsHumansSwineTissue Scaffoldscornea transplantationdecellularizationporcine xenografttissue engineering

Identifiers

PMID31659811
PMCPMC6908750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.